Where IDEAYA Biosciences Stands With Analysts
Portfolio Pulse from Benzinga Insights
IDEAYA Biosciences (NASDAQ:IDYA) has received 8 analyst ratings in the last quarter, with 1 being bullish and 7 somewhat bullish. The average price target is $35.5, compared to the current price of $26.92, implying an upside. The average price target has increased by 9.81% over the past month.
October 11, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
IDEAYA Biosciences has received positive analyst ratings, which could lead to an increase in its stock price.
Analyst ratings are a significant factor that investors consider when making investment decisions. The positive ratings for IDEAYA Biosciences indicate a positive outlook for the company, which could lead to an increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100